国际外科学杂志
國際外科學雜誌
국제외과학잡지
INTERNATIONAL JOURNAL OF SURGERY
2013年
4期
230-232,封3
,共4页
俞渊%徐明月%史宪杰%万涛%王宏光%纪文斌%梁雨荣
俞淵%徐明月%史憲傑%萬濤%王宏光%紀文斌%樑雨榮
유연%서명월%사헌걸%만도%왕굉광%기문빈%량우영
腹腔镜%射频消融术%肝细胞癌
腹腔鏡%射頻消融術%肝細胞癌
복강경%사빈소융술%간세포암
Laparoscopes%Radiofrequencyablation%Hepatocellularcarcinoma
目的 探讨经腹腔镜射频消融术治疗肝细胞癌的临床疗效及相关并发症.方法 采用腹腔镜射频消融术对68例肝癌病灶进行治疗,观察术后恢复情况、病灶坏死率,复发率及1年生存率等.结果 68例患者均顺利完成手术,腹腔镜探查新发现20个术前影像学漏诊病灶.累计治疗病灶114个.术后未出现严重并发症,平均住院时间(2.5±1.2)d,3个月病灶坏死率为85.9%(98/114),6个月病灶复发率为12.2%(14/114),1年生存率为76.47%.结论 经腹腔镜射频消融治疗肝细胞癌具有安全性高、并发症少、住院时间短及临床疗效显著等优势,值得临床推广.
目的 探討經腹腔鏡射頻消融術治療肝細胞癌的臨床療效及相關併髮癥.方法 採用腹腔鏡射頻消融術對68例肝癌病竈進行治療,觀察術後恢複情況、病竈壞死率,複髮率及1年生存率等.結果 68例患者均順利完成手術,腹腔鏡探查新髮現20箇術前影像學漏診病竈.纍計治療病竈114箇.術後未齣現嚴重併髮癥,平均住院時間(2.5±1.2)d,3箇月病竈壞死率為85.9%(98/114),6箇月病竈複髮率為12.2%(14/114),1年生存率為76.47%.結論 經腹腔鏡射頻消融治療肝細胞癌具有安全性高、併髮癥少、住院時間短及臨床療效顯著等優勢,值得臨床推廣.
목적 탐토경복강경사빈소융술치료간세포암적림상료효급상관병발증.방법 채용복강경사빈소융술대68례간암병조진행치료,관찰술후회복정황、병조배사솔,복발솔급1년생존솔등.결과 68례환자균순리완성수술,복강경탐사신발현20개술전영상학루진병조.루계치료병조114개.술후미출현엄중병발증,평균주원시간(2.5±1.2)d,3개월병조배사솔위85.9%(98/114),6개월병조복발솔위12.2%(14/114),1년생존솔위76.47%.결론 경복강경사빈소융치료간세포암구유안전성고、병발증소、주원시간단급림상료효현저등우세,치득림상추엄.
Objective To evaluate the feasibility,safety and efficacy of laparoscopic radiofrequency ablation (RFA) therapy for hepatocellular carcinoma (HCC).Methods Sixty-eight cases of liver cancer lesions were underwent laparoscopic radiofrequency ablation,and their postoperative recovery state,focal necrosis rate were observed.Results All the 68 cases were successfully performed operation,114 lesions were treated including 20 missed lesions at preoperative imaging diagnosis.There were no serious postoperative complications,the average hospital stay was (2.5 ± 1.2) days,focal necrosis rate 3 months after operation was 85.9%,lesion recurrence rate 6 months after operation was 12.2%,the 1-year survival rate was 76.47%.Conclusions Laparoscopic radiofrequency ablation in treatment of hepatocellular carcinoma has high security,few complications,short hospital stay and remarkable clinical effects.It's well worth clinical outreach.